United States · FDA National Drug Code directory
LEVETIRACETAM
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70752-203_339d66da-457a-4267-806b-7673122db283
- Product NDC
- 70752-203
- Form
- SOLUTION
- Composition / generic term
- LEVETIRACETAM
- Labeler
- QUAGEN PHARMACEUTICALS LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250201
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVETIRACETAM — 100 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 CUP, UNIT-DOSE in 1 TRAY (70752-203-02) / 15 mL in 1 CUP, UNIT-DOSE · 70752-203-02
- 473 mL in 1 BOTTLE (70752-203-12) · 70752-203-12
- 10 CUP, UNIT-DOSE in 1 TRAY (70752-203-16) / 5 mL in 1 CUP, UNIT-DOSE · 70752-203-16
- 10 CUP, UNIT-DOSE in 1 TRAY (70752-203-27) / 10 mL in 1 CUP, UNIT-DOSE · 70752-203-27
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →